This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| ChREBP | |
|---|---|
| Name | Carbohydrate-responsive element-binding protein |
| Organism | Homo sapiens |
| Chromosome | 7q11.23 |
| Family | bHLH-Zip transcription factors |
ChREBP
Carbohydrate-responsive element-binding protein (ChREBP) is a basic helix–loop–helix leucine zipper transcription factor that coordinates transcriptional responses to carbohydrate availability in mammals, linking nutrient sensing to lipid and glucose metabolism. Discovered through studies of hepatic gene regulation, it functions together with MLX-family partners to regulate glycolytic and lipogenic gene networks in liver, adipose tissue, and pancreatic islets. ChREBP activity integrates signaling cascades implicated in metabolic diseases and has been studied using genetic, biochemical, and structural approaches.
ChREBP functions as a glucose-responsive transcriptional regulator that binds carbohydrate response elements in promoters and enhancers of target genes, cooperating with cofactors to control expression of enzymes such as ATP citrate lyase, fatty acid synthase, pyruvate kinase, liver and RBC, acetyl-CoA carboxylase alpha, and stearoyl-CoA desaturase-1. It forms heterodimers with MLX to engage chromatin and recruit chromatin remodelers and co-activators including complexes related to CBP, p300, and the Mediator complex. Mechanistically, ChREBP senses intracellular metabolites generated by pathways such as glycolysis, the pentose phosphate pathway, and the tricarboxylic acid cycle, translating nutrient status into altered transcription of metabolic and secretory programs implicated in systemic energy balance. In physiology, ChREBP-driven transcription interfaces with hormone-regulated networks including signaling mediated by insulin, glucagon, and growth factors that act through kinases like AMP-activated protein kinase and protein kinase A.
The ChREBP polypeptide contains canonical domains of the basic helix-loop-helix leucine zipper family, including an N-terminal glucose-sensing regulatory region, a DNA-binding bHLH domain, and C-terminal transactivation domains that recruit co-regulators such as Mediator subunit 1. Alternative promoter usage and splicing generate tissue-restricted isoforms with differential activity and localization, paralleling isoform diversity seen in transcription factors such as SREBP1 and PPAR alpha. Structural insights have been informed by comparisons to solved bHLH-Zip structures like Max (protein), Myc (transcription factor), and USF1, and by domain mapping using mutational analysis and peptide-interaction studies analogous to investigations of CREB-binding protein interactions.
ChREBP activity is regulated by post-translational modifications including phosphorylation, O-GlcNAcylation, and acetylation, with key modifying enzymes such as AMPK, protein kinase A, O-GlcNAc transferase, and histone acetyltransferases influencing nuclear localization and DNA binding. Phosphorylation sites modulate cytosolic retention versus chromatin association, a regulatory logic shared with transcription factors like FOXO1 and SREBF1. Proteasomal turnover of ChREBP involves ubiquitin–proteasome pathway components analogous to those regulating p53 and HIF1A, while interactions with chaperones and nuclear transport factors mirror mechanisms described for NF-κB and STAT3.
ChREBP orchestrates transcription of glycolytic and lipogenic programs in hepatic, adipose, and endocrine tissues, impacting systemic lipid storage, triglyceride synthesis, and de novo lipogenesis. Its action influences physiological processes including postprandial nutrient partitioning, hepatic steatosis susceptibility, and insulin secretory capacity in pancreatic islets, intersecting with pathways regulated by PPAR gamma, SREBP2, and mTOR complex 1. ChREBP-driven metabolites contribute to signaling through lipid mediators and glycation products linked to vascular and hepatic physiology studied in contexts such as the Framingham Heart Study-style cohorts and experimental diets modeled after Western diet paradigms.
Dysregulation of ChREBP is implicated in metabolic disorders including nonalcoholic fatty liver disease, type 2 diabetes mellitus, dyslipidemia, and cardiometabolic risk states observed in population studies like UK Biobank. Altered ChREBP signaling contributes to hepatic triglyceride accumulation, insulin resistance, and aberrant lipoprotein profiles that are monitored clinically using biomarkers such as alanine transaminase and serum triglycerides. Genetic and pharmacologic modulation of ChREBP pathways has been explored as therapeutic strategies in preclinical models and linked to drug-discovery efforts involving targets validated in studies of metformin and fibrate pharmacology.
ChREBP has been studied using genetic knockouts, conditional alleles, and transgenic overexpression in murine systems including models generated with CRISPR-Cas9 and Cre-loxP strategies similar to those used for Ins1-Cre and Albumin-Cre lines. Biochemical assays employ electrophoretic mobility shift assays, chromatin immunoprecipitation followed by sequencing used in genome projects like ENCODE, mass spectrometry for post-translational modification mapping, and metabolomics platforms akin to those deployed in Metabolomics Workbench studies. Cell-based assays use hepatocyte cultures, adipocyte differentiation systems, and pancreatic beta-cell lines paralleling methods applied to study INS-1 and HepG2 cell models.
ChREBP orthologs are conserved across vertebrates and have functional analogs in invertebrate nutrient-sensing systems; comparative genomics places the MLXIPL locus within syntenic blocks conserved among mammals, birds, and teleost fish. Evolutionary analyses draw on phylogenomic resources such as Ensembl and NCBI Gene to trace domain conservation relative to other bHLH-Zip family members including Max, Myc, and Mlx. Functional conservation has been examined in model organisms from Mus musculus to Danio rerio, informing translational insights into metabolic regulation across taxa.
Category:Transcription factors